Fennec Pharmaceuticals (FENC) Times Interest Earned (2021 - 2025)
Fennec Pharmaceuticals filings provide 7 years of Times Interest Earned readings, the most recent being $7.19 for Q4 2025.
- On a quarterly basis, Times Interest Earned rose 843.12% to $7.19 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.73, a 215.49% decrease, with the full-year FY2025 number at -$0.73, down 215.41% from a year prior.
- Times Interest Earned hit $7.19 in Q4 2025 for Fennec Pharmaceuticals, up from -$0.32 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $13.29 in Q1 2024 to a low of -$1230.8 in Q1 2021.
- Median Times Interest Earned over the past 5 years was -$5.08 (2024), compared with a mean of -$104.02.
- Biggest five-year swings in Times Interest Earned: crashed 327.17% in 2024 and later skyrocketed 843.12% in 2025.
- Fennec Pharmaceuticals' Times Interest Earned stood at -$75.87 in 2021, then surged by 91.15% to -$6.71 in 2022, then soared by 70.4% to -$1.99 in 2023, then skyrocketed by 51.34% to -$0.97 in 2024, then surged by 843.12% to $7.19 in 2025.
- The last three reported values for Times Interest Earned were $7.19 (Q4 2025), -$0.32 (Q3 2025), and -$4.6 (Q2 2025) per Business Quant data.